EAVI2020 at the “Toolkits for DNA vaccine design, an update” conference in Moscow
17-21 November 2016
Dr Joan Joseph from Fundació Clínic per a la Recerca Biomèdica presented lessons learned on “Pre-clinical development of recombinant BCG based HIV vaccine” at the event, which took place at the Mechninov´s Institute of Vaccine and Sera in Moscow from the 17th to 21st November 2016.
The conference covered the whole area of DNA vaccine design starting from gene design, defining of transcription and translation signals, packaging, delivery, induction of innate immune response and role of adjuvants, induction and expansion of adaptive immune response, prime and boost strategies, success of DNA vaccines in cancer and infectious diseases, comparison of DNA vaccines to other vaccine modalities.
Representatives of R&D companies and state agencies involved in the development, production and distribution of vaccines were also invited to discuss the business models for DNA vaccines, public perception of the vaccines and their perspectives for human and veterinarian use.